Caitlyn Krebs

Caitlyn Krebs

Company: Nalu Bio

Job title: Co-Founder & Chief executive officer

Seminars:

Synthetic Cannabinoid Case Study: Endometriosis 4:00 pm

Understanding the development of synthetic cannabinoids through advanced AI platforms and in silico modelling to design novel synthetic compounds Illustrating how these compounds bind to CB1 and CB2 receptors and how their activity can be biased A case study to explore the connection between the endocannabinoid system and endometriosis, emphasizing cannabinoid intervention as a promising…Read more

day: Day One - Afternoon

Panel Discussion: Explore How Industry Leaders are Navigating the Challenges of Bringing Cannabinoid Based Therapies to Women’s Health 4:30 pm

Explore effective strategies to engage and educate patients, clinicians, and advocacy groups to drive awareness and increase participation in cannabinoid clinical trials for endometriosis. Identify the key regulatory, societal, and commercial barriers limiting patient access to cannabinoid-based therapies and evaluating solutions Examine how industry collaboration, policy evolution, and patient advocacy can work together to accelerate…Read more

day: Day One - Afternoon

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.